Three of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows.
Jul 11, 2024
0
0
Cassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a teenager growing up in northeastern Pennsylvania, she saw numerous neurologists and tried a variety of medications before finding ...
Jun 20, 2024
0
0
Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy (ADT), yet many patients ...
May 31, 2024
0
0
About 1 in 8 U.S. adults (12%) have tried a weight-loss drug like Wegovy, Ozempic, Zepbound or Mounjaro, a new KFF Health Tracking Poll says.
May 10, 2024
0
0
The US Food and Drug Administration has given the green light for a popular anti-obesity drug to be used to prevent serious heart conditions for the first time, in a move likely to expand insurance coverage.
Mar 9, 2024
0
1
With the life-saving, COVID-fighting drug Paxlovid no longer covered by the federal government, a push is underway in Albany to ensure New Yorkers seeking the medication do not get gouged by pricey co-payments.
Jan 23, 2024
0
0
New data released today by the Center for Public Health Law Research (CPHLR) at Temple University Beasley School of Law point to continued legal barriers for justice-involved seeking continuity of care through Medicaid coverage ...
Jan 11, 2024
0
0
Medication abortion is the preferred method of ending pregnancy in the U.S., and one of the two drugs used—mifepristone—will now go in front of the U.S. Supreme Court next year.
Dec 13, 2023
0
0
Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world's biggest drug developers are tapping into the growing treatment market.
Nov 16, 2023
0
0
More than half of working-age Americans struggle to afford their health care and many forgo care, possibly risking their health, according to a new survey.
Oct 26, 2023
0
0
